-

$undefined

N/A

(N/A)

Acelyrin Inc. :SLRN

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-164.8M

Cash

635.2M

Avg Qtr Burn

-54.08M

Short % of Float

11.19%

Insider Ownership

8.14%

Institutional Own.

-

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Izokibep Details
Hidradenitis suppurativa

Phase 3

Update

Izokibep Details
Axial spondyloarthritis

Phase 3

Initiation

Izokibep Details
Psoriatic arthritis

Phase 2/3

Data readout

Izokibep Details
Uveitis , Eye disease

Phase 2/3

Data readout

Lonigutamab Details
Thyroid Eye Disease , Eye disease

Phase 2

Data readout

SLRN-517 Details
Allergy, KIT/Mast cell diseases, Inflammatory disease

Phase 1/2

Data readout